News

2023.03.21

Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent

According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ ...

Read

2023.03.07

In February, the company announced plans for a share issue of up to 1.64 million shares, which will represent 14 percent of the company’s ...

Read

2023.02.28

The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the ...

Read

2023.02.16

On 16th February 2023, Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange Video from the debut: ...

Read

2023.02.09

16 February 2023 – the date for Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange. We have great pleasure to invite all ...

Read

2023.01.25

In the next few days, the company expects to apply to the Warsaw Stock Exchange for admission and listing of Genomtec S.A. shares on the Warsaw ...

Read